Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: A precisely timed mRNA shot could help many cancer patients live longer.

In a development that could shape cancer treatment strategies, researchers have found evidence that COVID mRNA vaccines can enhance the effectiveness of cancer immunotherapy and significantly improve ...

In a surprising discovery, a 'sticky molecule' that occurs naturally in our blood vessels could be both a culprit behind ...

For the quarter ended September 2025, Moderna (MRNA) reported revenue of $1.02 billion, down 45.4% over the same period last year. EPS came in at -$0.51, compared to $0.03 in the year-ago quarter. The ...

Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...

The story of the pharmaceutical company Moderna almost reads like a Hollywood screenplay. In its relatively short life, it ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Earlier this month, a group of Canadian researchers published early influenza data for the 2025-26 season, issuing a warning: ...